Sugi Predict

Sugi Predict / Compounds / 2-(4-Chlorphenoxy)-Ethanol

2-(4-Chlorphenoxy)-Ethanol

2-(4-Chlorphenoxy)-Ethanol

SCHEMBL77500

OCCOc1ccc(Cl)cc1

nearest known ligand 0.60

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 1/20 0.60
▸ RECQL P46063 1/20 0.60
▸ NR1I2 O75469 1/20 0.53
▸ GAA P10253 1/20 0.50
▸ DRD4 P21917 4/20 0.48
▸ DRD2 P14416 3/20 0.48
▸ DRD3 P35462 3/20 0.48
▸ SMN1; SMN2 Q16637 2/20 0.48
▸ CYP3A4 P08684 2/20 0.48
▸ KCNH2 Q12809 2/20 0.48
▸ ALDH3A1 P30838 1/20 0.47
▸ NPC1 O15118 1/20 0.47
▸ RAB9A P51151 1/20 0.47
▸ CYP1A2 P05177 1/20 0.46
▸ CYP2C19 P33261 1/20 0.46
▸ MAOB P27338 2/20 0.46
▸ NPSR1 Q6W5P4 1/20 0.46
▸ LTA4H P09960 1/20 0.46
▸ PTGS2 P35354 1/20 0.46
▸ BLM P54132 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
2-(4-Chlorphenoxy)-Ethanol SCHEMBL11264357 0.98 ALDH1A1 (0.58) ALDH1A1RECQLNR1I2GAADRD4
SCHEMBL11538545 0.94 LTA4H (0.54) ALDH1A1RECQLNR1I2GAADRD4
SCHEMBL11358240 0.90 LTA4H (0.57) ALDH1A1RECQLNR1I2GAAMAOB
SCHEMBL4383977 0.88 DRD4 (0.52) ALDH1A1RECQLDRD4DRD2DRD3
SCHEMBL14173682 0.88 NR1I2 (0.49) ALDH1A1RECQLNR1I2GAADRD4
SCHEMBL10877572 0.88 ALDH1A1 (0.48) ALDH1A1RECQLNR1I2GAADRD4
SCHEMBL10775850 0.87 APP (0.57) ALDH1A1RECQLDRD4SMN1; SMN2CYP3A4
SCHEMBL10775952 0.87 APP (0.57) ALDH1A1RECQLDRD4SMN1; SMN2CYP3A4
SCHEMBL48239 0.87 ALDH1A1 (0.75) ALDH1A1RECQLNR1I2GAASMN1; SMN2
SCHEMBL28106819 0.87 ALDH1A1 (0.75) ALDH1A1RECQLNR1I2GAASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 406 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240199542-A1 SUBSTITUTED PYRROLIDIN-2-ONES, SALTS THEREOF AND THEIR USE AS HERBICIDALLY ACTIVE SUBSTANCES BAYER AKTIENGESELLSCHAFT (DE) 2024-06-20 — — US claimed
EP-4313943-A1 SUBSTITUTED PYRROLIDIN-2-ONES, SALTS THEREOF AND THEIR USE AS HERBICIDALLY ACTIVE SUBSTANCES Bayer Aktiengesellschaft (DE) 2024-02-07 — — EP claimed
CN-117043140-A Substituted pyrrolidin-2-ones, salts thereof and their use as herbicidal active substances 拜耳公司 2023-11-10 — — CN claimed
WO-2022200208-A1 SUBSTITUTED PYRROLIDIN-2-ONES, SALTS THEREOF AND THEIR USE AS HERBICIDALLY ACTIVE SUBSTANCES BAYER AKTIENGESELLSCHAFT (DE) 2022-09-29 — — WO claimed
CN-109111595-B Novel silicon-based flame retardant and preparation method and application thereof 扬州工业职业技术学院 2021-04-23 — — CN claimed
EP-3503874-A1 METHODS AND COMPOSITIONS FOR TREATING CUTANEOUS FUNGAL INFECTIONS Schanbacher, Carl, F. (US) 2019-07-03 — — EP claimed
CN-109862882-A Methods and compositions for treating fungal infections of the skin 卡尔·F·尚巴赫 2019-06-07 — — CN claimed
WO-2018044621-A1 METHODS AND COMPOSITIONS FOR TREATING CUTANEOUS FUNGAL INFECTIONS SCHANBACHER CARL L (US) 2018-03-08 — — WO claimed
US-20180055745-A1 Methods and Compositions for Treating Cutaneous Fungal Infections PROPEDIX, INC. 2018-03-01 — — US claimed
US-20170312312-A1 Chlorite-Containing Compositions CLEARCRESCENT TECHNOLOGIES, LLC 2017-11-02 — — US claimed
US-20090215888-A1 TOPICAL NAIL FORMULATION NUVO RESEARCH INC. (CA) 2009-08-27 — — US claimed
WO-2009062746-A2 TOPICAL DRUGS FOR USE IN ANTIFUNGAL THERAPY BAYER CONSUMER CARE AG (CH) 2009-05-22 — — WO claimed
WO-2007098591-A2 TOPICAL NAIL FORMULATION NUVO RESEARCH INC. (CA) 2007-09-07 — — WO claimed
EP-0306453-B1 PROCESS FOR THE PREPARATION OF 2-(2-CHLOROETHOXY)-BENZOSULFON AMIDE CIBA-GEIGY AG (CH) 1993-01-20 — — EP claimed
US-4959501-A Process for the preparation of 2-(2-chloroethoxy)-benzenesulfonamide CIBA-GEIGY CORPORATION (US) 1990-09-25 — — US claimed
EP-0306453-A2 Process for the preparation of 2-(2-chloroethoxy)-benzosulfon amide CIBA-GEIGY AG (CH) 1989-03-08 — — EP claimed
EP-0122151-B1 PRODUCTION OF PRIMARY OR SECONDARY ALCOHOL DERIVATIVES OF PHOSPHOLIPIDS BY THE ENZYMATIC TECHNIQUE MEITO SANGYO KABUSHIKI KAISHA (JP) 1989-02-15 — — EP claimed
US-4783402-A Production of primary or secondary alcohol derivatives of phospholipids by the enzymatic technique MEITO SANGYO KABUSHIKI KAISHA (JP) 1988-11-08 — — US claimed
EP-0122151-A2 Production of primary or secondary alcohol derivatives of phospholipids by the enzymatic technique MEITO SANGYO KABUSHIKI KAISHA (JP) 1984-10-17 — — EP claimed
US-4057648-A 5-CHLORO-2-(2,4-DICHLOROPHENOXY)-PHENOL AND 2-PHENOXYETHANOL OR 2-(P-CHLOROPHENOXY)-ETHANOL CIBA-GEIGY CORPORATION (US) 1977-11-08 — — US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240199542-A1 SUBSTITUTED PYRROLIDIN-2-ONES, SALTS THEREOF AND THEIR USE AS HERBICIDALLY ACTIVE SUBSTANCES HPD, DDT, PPOX ALDH1A1 315/4885RECQL 3095/4885NR1I2 3247/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.